Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy.
Saved in:
| Title: | Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy. |
|---|---|
| Authors: | Merseburger, Axel S.1 (AUTHOR) axel.merseburger@uksh.de, Agarwal, Neeraj2 (AUTHOR), Bjartell, Anders3 (AUTHOR), Uemura, Hirotsugu4 (AUTHOR), Soto, Alvaro Juarez5 (AUTHOR), Bhaumik, Amitabha6 (AUTHOR), Böhm, Jürgen7 (AUTHOR), Tran, Nguyen7 (AUTHOR), Krochmann, Nils7 (AUTHOR), Nematian‐Samani, Mehregan7 (AUTHOR), Mundle, Suneel D.8 (AUTHOR), Brookman‐May, Sabine D.9,10 (AUTHOR), Lopez‐Gitlitz, Angela11 (AUTHOR), McCarthy, Sharon A.8 (AUTHOR), Chi, Kim12 (AUTHOR), Chowdhury, Simon13 (AUTHOR) |
| Source: | BJU International. Dec2024, Vol. 134 Issue 6, p982-991. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14644096 |
|---|---|
| DOI: | 10.1111/bju.16449 |
